Science Will Win

Our Products
Grid_790x500.png
Grid_1000x450.jpg

Science Will Win

When science wins, we all win. Shop and share the collection, available in the U.S. only.
All profits from The Pfizer Store will be donated to charity.

SHOP THE PFIZER COLLECTION

Meet Ramcess Jean-Louis

Our People
Ram-Headshot_380x500_0.png
Ram-Headshot_1000x450.png

Meet Ramcess Jean-Louis

Ready to build on Pfizer’s commitment to Diversity, Equity, and Inclusion

Read More

The Truth About COVID-19 and "Black Fungus"

Your Health
Black-Fungus_380X500_0.jpg
Black-Fungus_1000X450_0.jpg

The Truth About COVID-19 and "Black Fungus"

Setting the record straight about a rare but fatal infection

LEARN MORE

Sickle Cell

Your Health
sickle-cell-trait-vs-sickle-cell-disease_790x500.png
sickle-cell-trait-vs-sickle-cell-disease_1000x450.jpg

Sickle Cell

Is there a difference between having sickle cell trait and sickle cell disease? Find out what steps to take if you or someone in your family is diagnosed with these conditions.

Read More

Search products

Search products, A–Z

Need help paying for Pfizer medicines?

pfizer-logo
Your search for a clinical trial starts here.
Learn more about the process of joining a clinical trial and find a trial near you.
Start now

LEARN ABOUT OUR CLINICAL TRIAL FOR PEOPLE RECENTLY DIAGNOSED WITH COVID-19

Our Science
learn_about_our_clinical_trial_380x500_0.png
learn_about_our_clinical_trial_1000x450.jpg

LEARN ABOUT OUR CLINICAL TRIAL FOR PEOPLE RECENTLY DIAGNOSED WITH COVID-19

Do you have COVID-19? We are currently enrolling participants in a clinical trial for a potential oral treatment option.

See If You Qualify

Visit Our COVID-19 Hub

Your Health
GettyImages-1208505315_790x500.png
GettyImages-1208505315_1000x450.jpg

Visit Our COVID-19 Hub

What you need to know about the virus and updates on how Pfizer is responding to the crisis.

Visit our resources

Latest News

Pfizer and OPKO Announce Extension of U.S. FDA…

NEW YORK, NY and MIAMI, FL September 24, 2021 - Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the Biologics License Application (BLA) for somatrogon, a once-weekly long-acting recombinant human growth hormone, for the treatment of growth hormone deficiency (GHD) in pediatric patients. The Prescription Drug User Fee Act (PDUFA) goal date has been extended by three months to January…

Read more